Hjem › Endometriekreft › California › Mountain View
Kliniske studier for Endometriekreft i Mountain View, CA
12 studier for Endometriekreft søker deltakere på steder i og rundt Mountain View (innen ca. 30 miles). Åpne et studie for å se hvem som kan delta og hvordan du kontakter studieteamet.
Offisiell studietekst (engelsk)
Rekrutterer til et studie her? Få det fremtredende øverst på siden – $99 i 30 dager →
Testing the Addition of an Antiangiogenic Drug (Bevacizumab) to Chemotherapy (Carboplatin and Paclitaxel) Combined With Immunotherapy (Pembrolizumab) for pMMR, TP53 Mutated Endometrial Cancer
RekruttererFase 3
- Stanford Cancer Institute Palo Alto, Palo Alto · 5 mi unna
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
RekruttererFase 2
- Stanford Cancer Institute Palo Alto, Palo Alto · 5 mi unna
- VA Palo Alto Health Care System, Palo Alto · 5 mi unna
A Study of PHST001 in Advanced Solid Tumors
RekruttererFase 1
- Stanford University School of Medicine, Palo Alto · 5 mi unna
A Study of LY4257496 in Participants With Cancer (OMNIRAY)
RekruttererFase 1
- Stanford University Medical Center, Stanford · 5 mi unna
Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
RekruttererFase 1/2
- Stanford Cancer Institute, Stanford · 5 mi unna
Phase 1, Safety and Tolerability Study of XmAb541 in Advanced Solid Tumors
RekruttererFase 1
- Stanford, Palo Alto · 5 mi unna
A Phase 2 Study of ACR-368 in Endometrial Adenocarcinoma
RekruttererFase 2
- Stanford Cancer Center, Palo Alto · 5 mi unna
FOG-001 in Locally Advanced or Metastatic Solid Tumors
RekruttererFase 1/2
- Stanford Cancer Institute, Stanford University, Palo Alto · 5 mi unna
Relacorilant in Combination With Different Treatment Regimens in Patients With Gynecological Cancers
RekruttererFase 2
- 150, Palo Alto · 5 mi unna
A Study of LY4175408 in Participants With Advanced Cancer
RekruttererFase 1
- Stanford Medicine Cancer Center, Stanford · 5 mi unna
A Study to Evaluate the Safety, Tolerability, and Efficacy of MORAb-202 (Herein Referred to as Farletuzumab Ecteribulin), a Folate Receptor Alpha (FRα)-Targeting Antibody-drug Conjugate (ADC) in Participants With Selected Tumor Types
RekruttererFase 1/2
- Stanford Women's Cancer Center, Palo Alto · 5 mi unna
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
RekruttererObservasjonsstudie
- Massive Bio SYNERGY-AI site, Stanford · 5 mi unna
Endometriekreft-studier i andre byer
- Houston, TX68 studier
- New York City, NY52 studier
- Boston, MA50 studier
- Arlington, VA39 studier
- Nashville, TN38 studier
- Los Angeles, CA34 studier
- St. Louis, MO29 studier
- Philadelphia, PA28 studier
- San Antonio, TX27 studier
- Columbus, OH25 studier
- Oklahoma City, OK25 studier
- Chicago, IL25 studier
Andre studier i Mountain View
- Kreft (alle typer)40 studier
- Brystkreft26 studier
- Metastatisk kreft25 studier
- Ikke-småcellet lungekreft21 studier
- Akut myelogen leukemi19 studier
- Eggstokkreft19 studier
- Autismespekterforstyrrelse17 studier
- Lungekreft17 studier
- Prostatakreft15 studier
- Hjertesvikt15 studier
- Autisme13 studier
- Akut lymfoblastisk leukemi13 studier
Fra ClinicalTrials.gov, data hentet 6. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.